Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 16, 2011Expert Opinion on Investigational DrugsOpen Access

Mechanisms of drug resistance in kinases

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRina Barouch‐BentovStanford UniversityKSKarsten SauerScripps Research Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Barouch‐Bentov et al. (2011) studied this question.

synapsesocial.com/papers/69ffd8572ff633f36577b676https://doi.org/10.1517/13543784.2011.546344
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Protein kinase inhibitors: contributions from structure to clinical compounds2009 · 256 citations
  2. 2EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation2008 · 133 citations
  3. 3Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions2009 · 66 citations
  4. 4Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges2008 · 49 citations
  5. 5T-Cell–Targeted Signaling Inhibitors2008 · 7 citations